James Triplett

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences


Dr James Triplett: James is a first year PhD candidate at the University of Adelaide, Faculty of Health and Medical Sciences.  James' PhD studies focus on the pathophysiology and neurophysiological markers of diabetic neuropathy including the association of abnormal sphingolipid metabolism in the development of diabetic neuropathy. He has published previously in neurophysiological techniques and a variety of neuromuscular and neuro-immunological conditions.

Date Position Institution name
2024 - ongoing Consultant Neurologist Flinders Medical Centre
2023 - 2024 Locum Consultant Neurologist Royal Adelaide Hospital
2022 - 2023 Locum Consultant Neurologist Royal Adelaide Hospital
2021 - 2022 Consultant Neurologist Gosford Hospital
2020 - ongoing Senior Clinical Lecturer University of Sydney
2020 - 2022 Consultant Neurologist Concord Repatriation General Hospital
2018 - 2020 Advanced Neurology Fellow Mayo Clinic
2018 - 2018 Neurophysiology Fellow Sir Charles Gairdner Hospital
2017 - 2018 Neuromuscular and Neuroimmunology Fellow Concord Repatriation General Hospital
2015 - 2017 Neurology Advanced Trainee Sir Charles Gairdner Hospital
2012 - 2015 Basic Physician Trainee Sir Charles Gairdner Hospital
2011 - 2012 Intern Sir Charles Gairdner Hospital

Date Institution name Country Title
2011 - 2014 University of Sydney Australia Masters of Medicine
2006 - 2010 University of Newcastle Australia Australia Bachelor of Medicine (Distinction)
2003 - 2005 University of Sydney Australia Bachelor of Medical Science

Year Citation
2025 Goh, R., Bellinge, J., Gim, H., Howson, S., El-Masri, S., Triplett, J., . . . Bacchi, S. (2025). Statewide neurology inpatient whole body and brain 18F-fluorodeoxyglucose positron emission tomography utilisation patterns demonstrate avenues for optimisation. Internal Medicine Journal, 55(2), 316-319.
DOI
2025 Calma, A. D., Triplett, J., Vucic, S., & Yiannikas, C. (2025). Somatosensory evoked potentials: technique, interpretation and clinical applications. Practical Neurology, 25(4), 337-344.
DOI
2025 Tan, S., Goh, R., Wright, A., Ng, J. S., Hains, L., Kovoor, J., . . . Bacchi, S. (2025). Epilepsy surgery candidate identification with artificial intelligence: An implementation study. Journal of Clinical Neuroscience, 135, 5 pages.
DOI Scopus1 WoS1 Europe PMC1
2025 Triplett, J. D., Pinto, M. V., Young, N. P., Staff, N. P., Chinmay, M. S., Horowitz, M., . . . Klein, C. J. (2025). GLP-1RA-Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies: A Case-Control Evaluation.. Neurology, 105(3), e213916.
DOI
2025 Hosseini-Marnani, E., Marathe, J. A., Triplett, J. D., Kamruzzaman, M., Yin, K., Jones, K. L., . . . Marathe, C. S. (2025). Gastric Autonomic Neuropathy in Diabetes. Endocrines, 6(3), 40.
DOI
2025 Burton, E., Satheakeerthy, S., Goh, R., Stretton, B., Booth, A. E. C., Gao, C., . . . Bacchi, S. (2025). Intravenous immunoglobulin weaning evaluation with zero-shot large language model classification. Transfusion Medicine, 5 pages.
DOI
2024 Rudaks, L. I., Triplett, J., Morris, K., Reddel, S., & Worgan, L. (2024). ACBD5-related retinal dystrophy with leukodystrophy due to novel mutations in ACBD5 and with additional features including ovarian insufficiency. American Journal of Medical Genetics Part A, 194(2), 346-350.
DOI Scopus5 Europe PMC5
2024 El-Wahsh, S., Morris, K., Limaye, S., Riminton, S., Corbett, A., & Triplett, J. D. (2024). Hypogammaglobulinemia and infection risk in myotonic dystrophy type 1. Muscle and Nerve, 70(5), 1034-1039.
DOI Scopus1 Europe PMC1
2024 Klein, C. J., Triplett, J. D., Murray, D. L., Gorsh, A. P., Shelly, S., Dubey, D., . . . Mills, J. R. (2024). Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation. Neurology, 103(11), e210000.
DOI Scopus4
2023 El-Wahsh, S., Triplett, J., & Yiannikas, C. (2023). Progressive Camptocormia with Head Drop and Dysphagia. JAMA Neurology, 80(2), 209-210.
DOI
2023 Oishi, T., Triplett, J. D., Laughlin, R. S., Hocker, S. E., Berini, S. E., & Hoffman, E. M. (2023). Short-Acting Neuromuscular Blockade Improves Inter-rater Reliability of Median Somatosensory Evoked Potentials in Post-cardiac arrest Prognostication. Neurocritical Care, 38(3), 600-611.
DOI Scopus5 WoS3 Europe PMC4
2023 El-Wahsh, S., Triplett, J., Robertson, A., & Yiannikas, C. (2023). Post-traumatic myasthenia gravis with head drop: insights into pathogenesis. Neurological Sciences, 44(9), 3347-3349.
DOI
2023 Nagaratnam, S., Harinesan, N., Wijesinghe, R., Wong-Doo, N., Lyons, A., Morris, K., & Triplett, J. (2023). Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis. Journal of Neuroimmunology, 377, 578061.
DOI
2023 Triplett, J. D., Lawn, N., & Edis, R. (2023). Teaching Neuro Images: New-onset focal epilepsy: The curious case of the camel and the jawbone. Neurology, 100(16), S36-S37.
DOI
2023 Shelly, S., Beecher, G., Milone, M., Liewluck, T., Ernste, F., Triplett, J., . . . Klein, C. J. (2023). Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation. Rheumatology (United Kingdom), 62(1), 281-289.
DOI Scopus12 WoS15 Europe PMC13
2022 Triplett, J. D., Kutlubaev, M. A., Kermode, A. G., & Hardy, T. (2022). Posterior reversible encephalopathy syndrome (PRES): Diagnosis and management. Practical Neurology, 22(3), 183-189.
DOI Scopus89 WoS91 Europe PMC93
2022 Triplett, J. D., Qiu, J., O'Brien, B., Gopinath, S., Trewin, B., Spring, P. J., . . . Hardy, T. A. (2022). Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome. European Journal of Neurology, 29(6), 1771-1781.
DOI Scopus27 WoS29 Europe PMC26
2022 Harinesan, N., Wijesinghe, R., Hayes, M., & Triplett, J. D. (2022). Cryolipolysis-associated radial mononeuropathy. Muscle and Nerve, 66(2), E6-E8.
DOI
2022 Dubey, D., Beecher, G., Hammami, M. B., Knight, A. M., Liewluck, T., Triplett, J., . . . Milone, M. (2022). Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. JAMA Neurology, 79(8), 808-816.
DOI Scopus24 WoS17 Europe PMC21
2021 Klistorner, A., Triplett, J. D., Barnett, M. H., Yiannikas, C., Barton, J., Parratt, J., . . . Graham, S. L. (2021). Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies. Journal of Clinical Neurophysiology, 38(3), 186-191.
DOI Scopus13 WoS12 Europe PMC11
2021 Triplett, J. D., Simpson, H. D., Clemmons, R. S., & Cascino, G. D. (2021). The effect of weight reduction surgery on the efficacy and tolerability of epilepsy pharmacotherapy. Epilepsy and Behavior, 124, 4 pages.
DOI Scopus10 WoS10 Europe PMC5
2021 Nicolau, S., Milone, M., Tracy, J. A., Mills, J. R., Triplett, J. D., & Liewluck, T. (2021). Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease. Muscle and Nerve, 64(6), 734-739.
DOI Scopus17 WoS16 Europe PMC15
2020 Shelly, S., Triplett, J. D., Pinto, M. V., Milone, M., Diehn, F. E., Zekeridou, A., & Liewluck, T. (2020). Immune checkpoint inhibitor-Associated myopathy: A clinicoseropathologically distinct myopathy. Brain Communications, 2(2), 16 pages.
DOI Scopus90 WoS70 Europe PMC72
2020 Triplett, J. D., Shelly, S., Livne, G., Milone, M., Kassardjian, C. D., Liewluck, T., . . . Klein, C. J. (2020). Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: Role of electrical myotonia. Brain Communications, 2(2), 10 pages.
DOI Scopus15 WoS6 Europe PMC12
2020 Triplett, J. D., Vijayan, S., Rajanayagam, S., Tuch, P., & Kermode, A. G. (2020). Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use. Multiple Sclerosis and Related Disorders, 40, 4 pages.
DOI Scopus29 WoS31 Europe PMC25
2020 Triplett, J. D., Pinto, M. V., Hosfield, E. A., Milone, M., & Liewluck, T. (2020). Myopathies featuring early or prominent dysphagia. Muscle and Nerve, 62(3), 344-350.
DOI Scopus10 WoS12 Europe PMC9
2020 Triplett, J., Kassardjian, C. D., Liewluck, T., Tahir, A., Lennon, V., Kopecky, S., & Milone, M. (2020). Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. Mayo Clinic Proceedings, 95(10), 2144-2149.
DOI Scopus25 WoS24 Europe PMC22
2020 Triplett, J. D., Khor, T. S., & Kermode, A. G. (2020). Recurrent upper limb neuropathies secondary to an epithelioid haemangioendothelioma – A rare mimic of nerve tumours. Journal of Clinical Neuroscience, 73, 326-328.
DOI Scopus2 WoS2 Europe PMC3
2019 Triplett, J., Kermode, A. G., Corbett, A., & Reddel, S. W. (2019). Warts and all: Fingolimod and unusual HPV-associated lesions. Multiple Sclerosis Journal, 25(11), 1547-1550.
DOI Scopus39 WoS35 Europe PMC30
2019 Triplett, J. D., Pamphlett, R., Wang, M. X., & Yiannikas, C. (2019). Anti-SRP associated necrotizing autoimmune myopathy presenting with asymptomatically elevated creatine kinase. Muscle and Nerve, 59(3), E17-E19.
DOI Scopus9 WoS7 Europe PMC8
2019 Triplett, J. D., Buzzard, K. A., Lubomski, M., Riminton, D. S., Barnett, M. H., Welgampola, M. S., . . . Hardy, T. A. (2019). Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes). Journal of Neurology Neurosurgery and Psychiatry, 90(8), 882-894.
DOI Scopus28 WoS26 Europe PMC22
2019 Triplett, J., Vijayan, S., Prince, R., & Kermode, A. (2019). Dimethyl fumarate–associated transient bone marrow oedema syndrome. Multiple Sclerosis Journal, 25(6), 876-879.
DOI Scopus2 WoS2 Europe PMC1
2019 Triplett, J., Rigney, L., Hardy, T. A., Barnett, Y., Hayes, M. W., Barnett, M., & Reddel, S. W. (2019). Forearm-predominant parainfectious myositis. Muscle and Nerve, 59(2), E7-E10.
DOI
2019 Triplett, J. D., & Yiannikas, C. (2019). Multifocal neuropathy and treatment-induced neuropathy of diabetes following diabetic ketoacidosis. Neurology and Clinical Neuroscience, 7(6), 357-360.
DOI
2019 Triplett, J. D., Lawn, N. D., & Dunne, J. W. (2019). Baclofen Neurotoxicity: A Metabolic Encephalopathy Susceptible to Exacerbation by Benzodiazepine Therapy. Journal of Clinical Neurophysiology, 36(3), 209-212.
DOI Scopus19 WoS16 Europe PMC12
2019 Triplett, J., Nicholson, G., Sue, C., Hornemann, T., & Yiannikas, C. (2019). Hereditary sensory and autonomic neuropathy type IC accompanied by upper motor neuron abnormalities and type II juxtafoveal retinal telangiectasias. Journal of the Peripheral Nervous System, 24(2), 224-229.
DOI Scopus6 WoS5 Europe PMC4
2019 Triplett, J. D., Robertson, A., & Yiannikas, C. (2019). Compressive Lateral Femoral Cutaneous Neuropathy Secondary to Sartorius Muscle Fibrosis. JAMA Neurology, 76(1), 109-110.
DOI Scopus5 WoS5 Europe PMC3
2019 Triplett, J. D., Benarroch, E. E., & Cutsforth-Gregory, J. K. (2019). Pure autonomic failure presenting as Harlequin syndrome. Autonomic Neuroscience Basic and Clinical, 220, 3 pages.
DOI Scopus4 WoS3 Europe PMC3
2019 Shelly, S., Mills, J. R., Martinez-Thompson, J. M., Rofforth, M. M., Pittock, S. J., Mandrekar, J., . . . Klein, C. J. (2019). IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS. Journal of Neurology Neurosurgery and Psychiatry, 91(3), 324-326.
DOI Scopus9 WoS8 Europe PMC5
2019 Triplett, J. D., Hardy, T. A., Riminton, D. S., Chu, S. Y. K., & Reddel, S. W. (2019). Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?. Muscle and Nerve, 60(3), 307-311.
DOI Scopus9 WoS8 Europe PMC7
2019 Triplett, J. D., Lawn, N. D., Chan, J., & Dunne, J. W. (2019). Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?. Journal of Clinical Neuroscience, 67, 163-166.
DOI Scopus27 WoS23 Europe PMC27
2018 Triplett, J., Vijayan, S., MacDonald, A., Lawn, N., McLean-Tooke, A., Bynevelt, M., . . . Chemmanam, T. (2018). Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression. Journal of Neuroimmunology, 323, 119-124.
DOI Scopus29 WoS25 Europe PMC23
2018 Triplett, J., Hee, G., McLean-Tooke, A., & Lucas, M. (2018). Long-term control of laryngeal plasma cell mucositis with systemic immunosuppression. BMJ Case Reports, 2018, bcr-2017-221333.
DOI Scopus4 Europe PMC3
2018 Triplett, J. D., Yiannikas, C., Barnett, M. H., Parratt, J., Barton, J., Graham, S. L., . . . Klistorner, A. (2018). Pathophysiological basis of low contrast visual acuity loss in multiple sclerosis. Annals of Clinical and Translational Neurology, 5(12), 1505-1512.
DOI Scopus9 WoS9 Europe PMC7
2017 Triplett, J. D., Lawn, N., & Edis, R. (2017). Teaching Neuro Images: New-onset focal epilepsy: The curious case of the camel and the jawbone. Neurology, 89(17), e216-e217.
DOI Scopus1 WoS1
2017 Carroll, G. J., Makin, K., Garnsey, M., Bulsara, M., Carroll, B. V., Curtin, S. M., . . . Lucas, M. (2017). Undetectable Mannose Binding Lectin and Corticosteroids Increase Serious Infection Risk in Rheumatoid Arthritis. Journal of Allergy and Clinical Immunology in Practice, 5(6), 1609-1616.
DOI Scopus8 WoS10 Europe PMC7
2012 Barraclough, A., Triplett, J., & Tuch, P. (2012). Brachial neuritis with phrenic nerve involvement. Journal of Clinical Neuroscience, 19(9), 1301-1302.
DOI Scopus11 WoS7 Europe PMC4

2024. Royal Australasian College of Physicians Research Entry Scholarship recipient

2018. Australian and New Zealand Association of Neurologists overseas training fellowship – Mayo Clinic Rochester, 2018-2019

Date Role Committee Institution Country
2024 - ongoing Member ANZAN Neurophysiology committee Australian and New Zealand Association of N eurologists Australia
2024 - ongoing Member Neuromuscular Society of Australia and New Zealand Education Commitee Neuromuscular Society of Australia and New Zealand Australia

Date Role Membership Country
2018 - ongoing Member Royal Australasian College of Physicians Australia
2018 - ongoing Member Australia and New Zealand Association of Neurologists Australia
2018 - ongoing Member Neuromuscular Society of Australia and New Zealand Australia

Connect With Me

External Profiles

Other Links